Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.1%

1 terminated out of 47 trials

Success Rate

97.0%

+10.5% vs benchmark

Late-Stage Pipeline

9%

4 trials in Phase 3/4

Results Transparency

3%

1 of 32 completed with results

Key Signals

1 with results97% success

Data Visualizations

Phase Distribution

45Total
Not Applicable (38)
Early P 1 (1)
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (3)

Trial Status

Completed32
Unknown9
Recruiting3
Withdrawn1
Enrolling By Invitation1
Terminated1

Trial Success Rate

97.0%

Benchmark: 86.5%

Based on 32 completed trials

Clinical Trials (47)

Showing 20 of 20 trials
NCT05151510Phase 4WithdrawnPrimary

Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department

NCT04732507Phase 2Enrolling By Invitation

Investigating the Minimum Number of Needling Required to Optimize Trigger Point Injections Outcome

NCT06338514Not ApplicableRecruitingPrimary

The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsal Myofascial Pain Syndrome.

NCT05429827Not ApplicableRecruitingPrimary

The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome

NCT06492148Not ApplicableRecruiting

Myofascial Release Technique in Women With Primary Dysmenorrhea

NCT06029413Not ApplicableCompleted

Myo vs. Myofascial Injection for Myofascial Trigger Points

NCT02838394Not ApplicableTerminatedPrimary

Dry Needling and Functional Improvement

NCT06273514Not ApplicableCompleted

Comparison the Effects of TECAR With Dry Needling in the Treatment of Myofascial Trigger Points

NCT06258070Not ApplicableCompleted

Clinical Performance of Therapeutic Use of BTX for Bruxism

NCT06013644Early Phase 1UnknownPrimary

Acupuncture, Dry Needle and Botox Injection in Management of Patient With Myofascial Pain Dysfunction Syndrome

NCT05873010Not ApplicableUnknownPrimary

Manual Compression and Stretching for The Myofascial Trigger Points in Upper Trapezius and Levator Scapulae

NCT05851742Not ApplicableUnknown

Effects of Myofascial Release and Electrical Stimulation in Chronic Pelvic Pain

NCT05816161Not ApplicableUnknownPrimary

Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction

NCT05617118Unknown

BTA vs Baclofen for Pelvic Myofascial Pain Syndrome

NCT05792111Phase 4UnknownPrimary

Caudal Epidural Steroid and Trigger Point Injection

NCT04401566Not ApplicableCompleted

Investigation of Acute Effects of Myofascial Trigger Point Release in Women With Chronic Pelvic Pain

NCT05664165Not ApplicableCompleted

The Efficiency of Dry Needling and Cold Spray-stretching Treatments

NCT05546203Not ApplicableCompleted

Trigger Point Treatment in Chronic Pelvic Pain

NCT05405959Not ApplicableCompleted

Kinesio Tape Application With EDF Technique on Active Trigger Points of Upper Trapezius Muscle

NCT05396196Not ApplicableCompletedPrimary

An Analysis of Kinesio® Tape With Manual Fascial Glide Application on Trigger Points in The Iliotibial Band

Scroll to load more

Research Network

Activity Timeline